A.R.T. Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-83,343
| Closed | -$1.5M | – | 223 |
|
|
2019
Q4 | $1.5M | Buy |
83,343
+44,900
| +117% | +$809K | 0.07% | 407 |
|
|
2019
Q3 | $779K | Sell |
38,443
-51,300
| -57% | -$1.04M | 0.04% | 665 |
|
|
2019
Q2 | $1.98M | Sell |
89,743
-13,200
| -13% | -$292K | 0.11% | 237 |
|
|
2019
Q1 | $1.4M | Buy |
+102,943
| New | +$1.4M | 0.08% | 352 |
|
|
2018
Q4 | – | Sell |
-75,440
| Closed | -$1.24M | – | 1354 |
|
|
2018
Q3 | $1.24M | Buy |
75,440
+42,500
| +129% | +$701K | 0.06% | 483 |
|
|
2018
Q2 | $461K | Buy |
32,940
+8,695
| +36% | +$122K | 0.02% | 956 |
|
|
2018
Q1 | $267K | Buy |
+24,245
| New | +$267K | 0.01% | 1175 |
|
|
2017
Q4 | – | Sell |
-13,099
| Closed | -$174K | – | 1401 |
|
|
2017
Q3 | $174K | Buy |
+13,099
| New | +$174K | 0.01% | 1157 |
|
|
2017
Q1 | – | Sell |
-33,400
| Closed | -$940K | – | 1450 |
|
|
2016
Q4 | $940K | Buy |
33,400
+24,900
| +293% | +$701K | 0.06% | 504 |
|
|
2016
Q3 | $227K | Buy |
+8,500
| New | +$227K | 0.07% | 446 |
|